The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Kane Biotech Inc down $0.01

Kane Biotech Inc closed sharply lower Friday, dropping $0.01 or 5.00% to $0.10. Over the last five days, shares have gained 5.56%, but are down 24.00% for the last 52 weeks, lagging the 5.18% return in the S&P TSX.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.05
Updated January 19 1:33 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-689.55%

Although this company's net profit margin is negative, it is above the industry average and implies that Kane Biotech Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.42%Sector:HealthcareIndustry:Biotechnology

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit0000
Total cost of revenue0000
Total operating expense1101
Selling / general / administrative1110
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total00-10
Operating income-1-100
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-1-10-1
Income after tax-1-10-1
Income tax, total--------
Net income-1-10-1
Total adjustments to net income--------
Net income before extra. items-1-10-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-10-1
Inc. avail. to common incl. extra. items-1-10-1
Diluted net income-1-10-1
Dilution adjustment--------
Diluted weighted average shares74464646
Diluted EPS excluding extraordinary itemsvalue per share-0.01-0.02-0.01-0.01
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.01-0.02-0.01-0.01